Online / Physical Event

2nd International Conference on

Cancer Science

Theme: Recent Developments and Advancements of Cancer Science

Event Date & Time

Event Location

Prague, Czech Republic

Brochure Program Abstract Registration ReaderBase Awards

20 Years Of Excellence in Scientific Events

14422635477

Performers / Professionals From Around The Globe

Conference Speaker

Dr. Dina Ron

PhD from Ben-Gurion University and postdoctoral studies from the National Cancer Institute, NIH,USA
Israel

Conference Speaker

Donglu Shi

Professor University of Cincinnati USA
USA

Conference Speaker

Dr. Wassil Nowicky

President Ukrainian Anti-Cancer Institute Austria
Austria

Conference Speaker

Dr. Weisi Yan

Director CyberKnife Program, University of South Alabama
USA

Conference Speaker

Dr. Jose Antonio Matute

Submedical director Mexico
Mexico

Conference Speaker

Dr. Dalal Akoury

Advanced Integrative Medicine Authorityâš•Authorâš•Media Contributor âš•Global Speakerâš•Healthcare Educator âš•Health-Preneur
USA

Conference Speaker

Ms .Andrea J. Wilson

Andrea J. Wilson founded Blue Faery
USA

Conference Speaker

Elaheh Madadi

MA biotechnology in Tabriz University of Medical sciences
Iran

Conference Speaker

Dr. Yu-Cheng Kuo

Taipei Medical University.Taiwan
Taiwan

Conference Speaker

Dr.Kenji Ohe

Associate professor at Faculty of Pharmaceutical Sciences,Fukuoka University,Japan.
Japan

Conference Speaker

Dr. Jiangwen Zhang

University of Hong Kong
Hong Kong

Conference Speaker

Dr. Dwayne N Jackson

The University of Western Ontario
Canada

Tracks & Key Topics

Cancer Science

About Conference

EuroSciCon extends its warm welcome to all its participants to CANCER SCIENCE 2019 scheduled on Febuary 19-20, 2019 at Prague, Czech Republic with a theme “Recent Developments and Advancements of Cancer Science". EuroSciCon organizes Global Events with Conferences, Symposiums and Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
 
We gladly welcome attendees all around the world for the hearing of the foremost recent innovations and inventions in the field of cancer. This Conference will provide a forum for exchange of ideas and authoritative views by leading scientists, industry specialists and also from the academicians of the best institutes from around the globe. Outstanding keynote speakers and well known leading scientists and experts from around the globe will be expected to share their knowledge and talk about various aspects related to various frontiers in the field of Cancer science. Our aspiration is to gather peer researchers, young scientists, academicians & industrialists to meet, discuss and share the knowledge that’s still more to be revealed. Gain and grab the knowledge. Conferences and symposia provide unlimited opportunities to strengthen the community, and are also the collective body of knowledge. We cordially encourage you to attend and contribute to one of the major events of 2019 on the field of Cancer science.  The conference will reveal the present and future aspects in the field of Cancer science which are the need of the hour for instant and précised treatment.
 
Conference Topics:
  • Organ-Defined Cancers
  • Cancer Biopsy
  • Alternative Medicine
  • Cancer Vaccination
  • Biomarkers In Cancer Diagnosis & Prognosis
  • Cancer Case Reports
  • Surgical Oncology
  • Oncology Nursing
  • Targeted Cancer Therapy
  • Cancer Metastasis
  • Nano Medicines In Cancer Treatment
  • Gynecologic Oncology
  • Cervical Cancer & Transgender Man
  • Cancer & Tumour Immunology
  • Radiation Oncology
  • Integrative Therapy
  • Novel Anti-Cancer Drugs
  • Artificial Intelligence & Scope In Cancer Therapy
  • Cancer Therapeutics & Novel Approaches
  • Cancer Pharmacology
  • Cancer Genetics
  • Cancer Stem Cell Therapy
Cancer Science & Oncology:
The branch of health care determines safety & efficacy of medications, devices, and diagnostics and also treatments intended for human use is termed Clinical Research These are used for the treatment purpose, prevention, diagnosis and relieving symptoms of the diseases. Clinical research varies from clinical practice. Clinical practice uses established, whereas in case of clinical research evidence is collected for establishing the new treatment. And “biological marker” .i.e. Biomarker refers to the category of medical signs or say objective indications of the medical state which is observed from outside the patient – and is measured accurately.
 
Who and Why??
Cancer Science – 2019 Conference brings together the specialists from all the aspects to meet and discuss the future of Oncology & Cancer in today’s world to thrive and survive with a better health. The conference will bring together  Directors, Doctors, Director of Laboratories, Universities, Industries, Delegates, Cancer Research specialists, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies, CRO’s, Healthcare Institutions, Market Research and Consulting Firms, Pharmaceutical Companies, Medical device specialist and all the interested participants willing to enhance and update the knowledge on Cancer Science.

 

Session/Tracks

Cancer has a differentiated nature, in association to organ specificity. All types of cancer have distinctive characters; the basic processes that cause cancer are similar in all forms of cancers. Based on the cancer location in the body organ, it is named as Organ Specific Cancers. The various types of cancers include Breast Cancer, Bone Cancers, Ovarian Cancer, Prostrate Cancer, Neck Cancer, Lung cancer, Head cancer, skin cancer, Bile duct cancer, anal cancer etc. The tumor burden progressively hinders with regular biochemical functions carried out by the host organs. Based on the differences in the cancer cells while they grow, lead to the development of the drug that targets the specific area, which is called Targeted Cancer Therapy. Targeted therapy will not act like Chemotherapy (affecting the parts that are not targeted). The stem cell therapy also provides various way for treating cancer. Cancer Therapy Conferences express various developing therapies for varied cancers.

Pancreatic malignancy rises when cells in the pancreas start to multiply rather to the typical normal and shape a mass. These tumor cells can attack different parts of the body. Pancreatic adenocarcinoma, is the most widely recognized and represents around 85% of cases Pancreatic tumor treatment may consolidate medical procedure alone, a blend of medical procedure and proton treatment, or proton treatment alone, and also chemotherapy. Despite when it is possible to absolutely remove the adenocarcinoma with medical procedure, the likelihood of productive pancreatic development treatment is low; proton treatment for pancreatic tumor might be used after medical procedure to improve contamination control, before medical procedure to specialist the pancreatic tumor, inciting all the more convincing medical procedure, or in lieu of medical procedure. When in doubt, chemotherapy is moreover considered Pancreas is an organ, which assumes a noteworthy job in absorption and hormone production.The diary stocks up data about Pancreatic disorders,Pancreatitis, Pancreatic tumor, Gall bladder side effects, Gallbladder illness, Pancreatitis indications, Acute pancreatitis, Pancreas torment, Chronic pancreatitis, Biliary dyskinesia, Inflamed pancreas, Gallstone pancreatitis, Pancreatic pipe, Acute pancreatitis side effects, Pancreas life structures, Swollen pancreas, Pancreatic compound substitution treatment, Hereditary pancreatitis, Proton treatment pancreatic malignancy, Pancreatectomy, strategies for location, distinctive treatments and propelled medications to conquer pancreatic scatters. Pancreatic Disorders and Therapy is a companion surveyed medicinal diary that incorporates an extensive variety of subjects in this field and makes a stage for the creators to contribute towards the diary

 
Track 3: Cancer Biopsy
Biopsy is a medical examination usually done by a surgeon, an interventional radiologist, or an interventional cardiologist concerning extraction of sample cells or tissues for scrutiny to determine the existence of a disease state. It is of two categories, the Excisional biopsy in which the affected tissues or cells are removed entirely and the Incisional biopsy in which some sample is extracted from the affected region for diagnosis. When cancer is suspected, the first attempt will be Excisional biopsy. In case it doesn’t work they go for incisional biopsy to determine whether the cancer is benign or malignant. If the area of suspicion is not found, X- rays or ultrasound can be used to trace the area, known as Ultra sound guided biopsy or Stereotactic guided biopsy. The safest mode of diagnosis and a minor surgical procedure is called Fine needle aspiration. A non-invasive method of diagnosing cancer is Liquid biopsy. Cancer pathogenesis is another important procedure after biopsy. Cancer Science and Therapy Conferences paves way towards a break-through in the field of cancer research.
The elective solution for growth is something which is given for the tumor patients as a substitute to the current treatments, which are not demonstrated by the Nourishment and Medication Organization - FDA. The Back rub treatment have demonstrated some great outcomes yet they are just brief. Different treatments like strong psychotherapy and entrancing shows extremely feeble outcomes. The Subjective treatment indicated direct advantages however again it is likewise brief. The recommendation for Music treatment is questionable, and certain natural obstructions are extremely harmful to some tumor patients. The Needle therapy Treatment is likewise being dominatingly utilized elective medications, yet with extremely frail outcomes. Every one of these medications will give just misleading impacts, simply that for growth treatment. Tumor Science Gatherings serves to investigations the simultaneous courses in growth treatment
Certain sorts of chemotherapy and radiation treatment can cripple the safe structure, putting harm patients at extended risk everlastingly undermining illnesses. Thusly, various tumor patients may need to get revaccinated against diseases they got vaccinations for as adolescents. Antibodies require a sound immune structure that is prepared to see and execute sickness causing germs. Besides, it takes a sound invulnerable system no under 2 weeks from the period of inoculation to start seeing and disposing of germs. That infers vaccination timing is also as basic as getting the inoculation itself. At the point when all is said in done, inoculations isn't recommended in the midst of chemotherapy or radiation treatment
Cancer Biomarkers are substances that act as indicators of the cancer site in the body. Usually biomarkers are computable indicators of the biological state in the body, a molecule that is unleashed by the tumor or in response to the presence of tumor. Biomarkers are used for the assessment of risk in cancer patients. They are specifically related with genetic mutations or epigenetic alterations that show a measurable way to find the tumor cells. The advantages of biomarkers are that they can be used as a diagnostic tool, and can also determine whether the tumor is localized or metastatic in nature. Cancer prognosis can be determined by biomarkers. Cancer recurrence is also being examined by the biomarkers.
Cancer case report give thorough details about the diagnosis, treatments,follow ups, and the demographic profile of the patient. The literature review of other patients may also be present in a report for reference. In cancer metastasis, the case report plays an important role for treating the patient. It makes for a good cancer therapy database which could be useful for education and research. The cancer pathogenesis and its effects can be depicted in a case report. The case report is considered to be an anecdotal evidence, something which is considered very personal. Statistical sampling of the cancer patients may also be present in a case report for  future reference. Cancer Therapy Conferences is a platform to innovate novel therapy for cancer.
 
 
A pediatric oncology office is a child harmful development center that treats babies, little youngsters, school-age kids, energetic adults and teenagers up to the age of 18 or 19. Pediatric oncology focuses have a colossal staff of pros, orderlies, researchers and physical counselors, all of whom are successfully connected with pondering children who are dergoing danger treatment.As a patient at a pediatric oncology office, adolescents get first rate care and treatment in a circumstance arranged unequivocally for increasingly energetic age social events. Various pediatric sickness centers are research workplaces, in which adolescent and high schooler patients encounter clinical fundamentals or get new, cutting edge sorts of treatment. Various pediatric danger centers make a kid neighborly condition for patients and their families. Pros work environments, calm rooms and sitting zones have an enticing, less-clinical feel. Social workers are close by to empower families to gain coaching courses of action and ground their child all through treatment. Pediatric oncologists are set up to talk with children and their people about infection treatment in habits that are basic for everyone to get it.A pediatric oncology office is a child harmful development center that treats babies, little youngsters, school-age kids, energetic adults and teenagers up to the age of 18 or 19. Pediatric oncology focuses have a colossal staff of pros, orderlies, researchers and physical counselors, all of whom are successfully connected with pondering children who are dergoing danger treatment.As a patient at a pediatric oncology office, adolescents get first rate care and treatment in a circumstance arranged unequivocally for increasingly energetic age social events. Various pediatric sickness centers are research workplaces, in which adolescent and high schooler patients encounter clinical fundamentals or get new, cutting edge sorts of treatment. Various pediatric danger centers make a kid neighborly condition for patients and their families. Pros work environments, calm rooms and sitting zones have an enticing, less-clinical feel. Social workers are close by to empower families to gain coaching courses of action and ground their child all through treatment. Pediatric oncologists are set up to talk with children and their people about infection treatment in habits that are basic for everyone to get it.
 
 
Targeted Cancer Therapy is one of the finest therapies in treating cancer. The cancer cells are treated by targeting and inhibiting specific molecules that are responsible for tumor progression. This blocking can be done by molecular medicine. It is better than the usual chemotherapy, which only hinders the uncontrollable tumor growth. Molecular medicine is an extensive field that uses various tools to define the molecular structure and its mechanism, recognize errors in genes and to develop molecular interferences to treat them. Since most of the molecules used for targeting are biopharmaceuticals, this can also be referred as Biotherapy. Apart from Biotherapy, the Targeted Cancer therapy can use Nano-engineered enzymes. These enzymes bind to the cancer cell so that the natural cell degradation system of the body kills,digests and eliminates it from the body. Organ-Defined Cancers can be effectively treated by the Targeted therapy. Cancer Therapy Conferences reveals broad range of knowledge about targeted therapies for treating cancer.
The spread of cancer from one part of the body to another part or to lymph nodes, which are not directly connected to each other, is called Cancer Metastasis. Cancer is considered as a deadly disease mainly because of its ability to spread in the body. Metastasis takes place through the blood stream or the lymph system. The most common metastasis parts of the body are the lungs, bones, liver and the brain. The metastatic cancer cells do not resemble the feature of cells where it is actually found but resembles the primary cancer cells i.e. it is considered as the next stage of primary cancer cells. All metastatic cancers are considered as advanced cancers. The cancer survival and treatment is influenced by whether the cancer cells are localized or spread to other parts. When the cancer starts to spread, it is very difficult to control. Even if the treatment is continued, it will be only palliative care. The pain control will be mostly by Anti-cancer drugs i.e. chemotherapy. Cancer Management is a multidisciplinary approach that deals with various types of cancer complications and its preventive measures. Cancer Conferences is an important key for both educational and clinical guidance for managing cancer patients.
Tumor is a gathering of illnesses driven by naturally nanostructural issues (e.g. DNA issues). In that capacity, there are evident advantages to medications utilizing nanoscale structures and procedures. Moreover, as nanotechnologies are creating at a quick rate, it is likely that numerous new topics will create inside the territory in the following couple of years. On account of this, Malignancy Nanotechnology means to give a gathering with the goal that the most encouraging rising topics ought to be pre-famous in the psyches of specialists working in one or, in reality, both of the controls of growth research or nanotechnology.
Nanomedicine ranges from the therapeutic uses of nanomaterials and organic gadgets, to nanoelectronic biosensors, and even conceivable future utilizations of sub-atomic nanotechnology, for example, natural machines. Current issues for nanomedicine include understanding the issues identified with poisonous quality and ecological effect of nanoscale (materials whose structure is on the size of nanometers, i.e. billionths
Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers. Gynecologic Oncology is a field of medication that spotlights on malignancies of the female conceptive system, including ovarian ailment, uterine development, vaginal tumor, cervical malady, and Vulvar danger. In Cancer science - 2019 speakers will discuss the key concentrations regarding immunotherapy, Insusceptible checkpoint inhibitors to treat ailment, and related examinations of tumor inoculation.As experts, they have wide planning in the assurance and treatment of these tumors.
Transgender Man is the quantifiably higher threat of cervical, ovarian, and uterine development looked by transgender men who hold genitalia they were considered with. In view of disgrace and social dismissal, various don't reliably get gynecological examinations and relating cervical and ovarian screenings. Transgender men are in peril for cervical ailment. Transgender individuals are particularly defenseless against a nonattendance of adequate social protection, particularly concerning sexual and regenerative prosperity. In most of the country's cervical development is a principle wellspring of threat death, transgender men are at high peril of working up this disease. Despite the fact that the Papanicolaou test is the most for the most part used screening system for cervical development, there are high amounts of inadmissible results among transgender men differentiated and nontransgender individuals. Human papillomavirus (HPV) testing may be a more functional screening decision in this masses.
 
Cancer immunology shows the relationship between the immune system and the progression of cancer. The cancer immunotherapy uses the immune system for the treatment of cancer. Cancer cells have some surface molecules on them that prevent the immune system from recognizing them as cancer cells. In immunotherapy those surface molecules are targeted and destroyed, so that immune cells can now identify the cancer cells. It is effective, specific, and long term than Chemotherapy and Surgery. Immunotherapy is something that stimulates the cells of immune system to attack the cells of tumor, and hence it can also be called as Biotherapy. To prevent the progression of neoplastic tissue, the immune system identifies the transformed cells which are called cancer immuno surveillance. Cancer Biomarkers are the best tool for recognizing the location of cancer, which is important for cancer treatment. Cancer Science and Therapy Conferences express great knowledge of therapies and treatments in the cancer field.
The usage of ionization radiation in cancer treatment is known as Radiation Oncology. Chemotherapy and radiation therapy are used as a combination to treat tumor. It also helps  reduce the tumor burden. Radiation therapy has some side effects, categorized into immediate and late side effects. The immediate side effects are vomitting, intestinal discomfort, swelling, infertility etc., The late side effects include fibrosis, epilation, heart diseases etc., Sometimes radiation enteropathy is also experienced by patients. Hormonal imbalances may also occur due to this therapy. Cancer metabolomics is an important tool for cancer detection and treatment. Cancer case reports show evidence for the effectiveness and side effects of radiation therapy. Cancer Science Conference discloses the recent innovations in cancer therapy field.
Integrative treatment is a dynamic type of psychotherapy that joins diverse remedial apparatuses and ways to deal with fit the necessities of the individual customer. With a comprehension of typical human improvement, an integrative advisor changes standard medicines to fill being developed holes that influence every customer in various ways. By joining components drawn from various schools of mental hypothesis and research, integrative treatment turns into a more adaptable and comprehensive way to deal with treatment than more conventional, solitary types of psychotherapy .Integrative therapy is more inclusive of the client than traditional forms of therapy, where the client plays a less active role in treatment. Integrative psychotherapists consider the individual characteristics, preferences, needs, physical abilities, spiritual beliefs, and motivation level of their clients and use their professional judgment to decide the best approach to therapy for each client. Different approaches may be used consecutively throughout different stages of the therapeutic process or they may be used as a single combined form of therapy throughout.
There are significant challenges to global drug development in the recent years. Despite vast research and development in the field of oncology, the translation of research advance into medicines that substantially improve the treatment of many cancers is witnessing slow growth. What could be the key challenges in anticancer drug development, and how can they be addressed? Some of the major threats the pharmaceutical industry is now facing, include the increase in the cost of research and development without an attenuated improvement in productivity (i.e, the number of agents approved), the longer duration of development without a corresponding decrease in development risk; and the increasingly conservative regulatory climate coupled with the increasingly difficult reimbursement setting. Cancer Science-2019 provides a global platform to share developments concerned to Anti-cancer drugs.
Artificial Intelligence in the treatment of cancer could be a break-through globally in the field of cancer. When cancer is detected at an early stage, treatment is more likely to be successful. But too often, cancers are diagnosed at a later stage when they are much harder to treat. There are many reasons for this, including that the symptoms people experience could be vague and linked to much less serious conditions. Detecting cancer earlier by interrogating medical and non-medical data sets using machine and deep-learning is a possible solution to prevent cancer or at the least, identify cancer at an early stage.
In cancer treatment the already existing treatments usually have many side effects and are highly poisonous, which could reduce the quality of life. This incorporates the discovery of novel approaches in cancer treatment. The most important approach is the cancer immunotherapy, in which the activation of immune system is done for the treatment of cancer. Traditionally the Cytokine therapy is considered as a backbone of immunotherapy. Peptide vaccines, tumor cell vaccines, immune cell vaccines, cancer vaccines are considered as a novelist finding in cancer field. In hematologic malignancy. the Adoptive Cell therapy is deliberated as a new practice for cancer therapy. The Molecular Cancer therapy is reflected as a novel approach in cancer treatment. Tumor Immunology plays an important role in verdict of new approaches for cancer therapeutics. Cancer Conferences expresses its effort to combat cancer.
Pharmacology deals with the study of action of drug in the body.  Though some drugs showed good results in animal model, were not effective when used in cancer patient of less tumor burden. In such cases the tumor burden is first reduced by cancer surgery and then followed by chemotherapy. This is called as adjuvant therapy. In combination with chemotherapy, a heat therapy called Hyperthermia therapy can be used to control various cancer types. Electric voltage passed through tumor cells to stop their progression along with chemotherapy process is known as Electro chemotherapy. The use of chemotherapy alone for cancer treatments leads to many side effects like cardiotoxicity, nephrotoxicity, ototoxicity etc., Cancer genetics is helpful for identifying the mode of treatment for Cancer. Cancer biomarkers effectively assist in finding tumor cells and treating them. Cancer Conferences gives a perception about the new strategies emerging in cancer therapy.
Track 21: Cancer Genetics
Cancer is a genetic disease triggered by an increase in DNA mutations and epigenetic alterations that leads to uncontrolled cell proliferation and neoplasm formation. Mutation occurs frequently in the body of human, but still can be controlled. So, it won’t be possible to cause cancer with one mutation. Generally, it takes numerous mutations in the lifetime of a human to cause cancer. This is the reason older people have cancer, as they have had multiple chances for mutations. Oncogenomics deals with the characterization of cancer- associated genes. Tumor suppressor genes or oncogenes are the ones that manage the cell cycle process, hence they are called the Protective cells. These genetic changes escalate the risk of cancer. The presence of mutated genes in germ cells can be inherited to the off springs. Cancer Pharmacology deals with studying the action of drugs on cancer patients. Cancer science meetings explore new ideas and techniques for cancer therapy.
As the name depicts, stem cells are used in this therapy for the treatment of some types cancer. An undifferentiated cell, that can be differentiated into a specific cell or multiple copies of the own cell is called stem cell. These stem cells are predominant in multicellular organisms. There are two kinds of stem cells, the Embryonic stem cells (derived from the blastocyst inner cell mass) and the Adult stem cells (derived from tissues of an adult). The Adult cells combined with the progenitor cells acts as a repair system of the body. During cancer therapies like chemotherapy, the stem cells could get destroyed due to high radiations. Stem cell transplants are generally used to treat or maintain stem cell level in cancer patients. There are many Cancer Case Reports showing this therapy as an effective treatment for cancer. Cancer Conferences act as a podium for gaining knowledge about the new inventions in cancer stem cell therapy.

Market Report

EuroScicon invites participants from across the globe to join the “International Conference on Cancer Science” going to be held during February 19-20, 2019Prague, Czech Republic. The conference includes Keynote Presentations, Oral Talks, Poster Presentations, Product Launches and Exhibitions. Cancer Science-2019 is a specially designed cluster conference, whose main theme is Recent Development and Advancements of Cancer Science . This event covers a wide spectrum of critically important sessions.

For more details please visit: https://cancerscience.euroscicon.com/

Importance & Scope: 

Cancer is the second highest leading cause of death in the world. It’s essential that we remember cancer is not one disease – it’s more than 200 cancer diseases involved, each of them different requiring respectively suitable approaches for their cure. Treatments that work for some cancers do not work for others, and there are some cases where treatments simply stop working abruptly, reasons being unknown. To overcome these problems, only a global search for answers is what is to be called for.

The conference will provide exceptional opportunities for Delegates from Universities and Institutes to interact with world-class Scientists and Industrial Professionals working in the field of cancer/oncology. Cancer Science 2019 will explore new ideas and advancements on a global scale in topics like Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Cancer Treatment & Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Frontiers in Cancer Science, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.

The Amsterdam Metropolitan Area is home to some of the world’s largest museums, iconic locations and the famous 400-year-old Canal Ring. Amsterdam is a top international destination for conventions and conferences, and hosts an average of 650 meetings per year, attracting over 700,000 business visitors. Visitors of all types have plenty to do while they’re here. The city’s cultural agenda is packed with world-class exhibitions, theatre performances, live music and other spectacular events, and its charming neighborhoods are full of shops, cafes and restaurants. The resources below will give an overview and helps you plan the right itinerary.

In the recent days, the Netherlands Cancer Institute - Anton van Leuwenhoek Hospital accommodates approximately 550 Scientists and Scientific Support Personnel, 53 Medical Specialists, 180 beds, an out-patients clinic with 30,600 visits, six operating theaters, and eleven Irradiation units. It is the only dedicated cancer center in the Netherlands, officially accredited as Comprehensive Cancer Center by the OECI, and holds importance as the National and International center for scientific and clinical expertise, development and training. The Cancer Center, Amsterdam houses one of the largest oncology research centers in the Netherlands, joining cancer researchers from the Academic Medical Center and the VU University Medical Center, Amsterdam. All researchers, clinicians, technicians, research nurses and other people involved in oncological research are invited to attend the conference, From the day the NKI-AVL was established, close collaboration between scientists and clinicians was seen as an essential element in fighting cancer. Having a laboratory and hospital under one roof in a single independent organization with an open and collaborative atmosphere has led to many important discoveries and improved therapies.

Market Analysis Report:

In the recent years there have been advancements & innumerable therapies and the search for cancer treatments has been accelerating. The recent reports on the global cancer diagnostics market for the forecast period of 2015 to 2020 speculates that this market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015, and is poised to grow at a Compound Annual Growth Rate (CAGR) of 12.9% during the forecast period. The global cancer diagnostics market is beholding a rapid transformation owing to several technological advancements in the diagnostic field.

BCC Research reports show the global market for next generation cancer diagnostic as $1.6 billion in 2013 which has reached $1.8 billion in 2014 and is expected to reach $10 billion in 2019, registering a compound annual growth (CAGR) of 42.6% over the five-year period.

The global cancer diagnostics market is segmented based on technology, application, and region.

Based on technology, the cancer diagnostics market is categorized into Platform-based and Instrument-based. The Instrument-based segment was expected to account for a major share of the cancer diagnostics market, in 2015. Based on the application, the cancer diagnostics market is segmented into Lung cancer, Breast cancer, Colorectal cancer, Melanoma, and others. Breast cancer application was expected to consider for a major share of the cancer diagnostics market, by application in 2015. Based on region, the market is divided into North America, Europe, Asia, and Rest of the World. Rest of the World part comprises Latin America, Pacific countries, and Middle East and Africa. North America is seen to reckon for the largest share in the cancer diagnostics market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.

Figure 1: Cancer Diagnostic Market by Region (2015- 2020)

The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound annual growth rate (CAGR) of 1.3% for the period 2014-2019, while the global cancer vaccines market is expected to grow at a CAGR of 12-18% over the period (2017 - 2022).  Global revenue for vaccine was nearly $31.8 billion in 2011. This market has increased from $33.6 billion in 2012 and is expected to increase to $43.4 billion in 2018 at a compound annual growth rate of 5.3%.

 

Figure 2: Cancer Vaccine Market Revenue (2014- 2019)

The global ovarian cancer drug and diagnostic market was valued at $16.1 billion in 2012 and $18.7 billion in 2013 and is expected to reach $34.6 billion by 2018, a compound annual growth rate of 13.1% between 2013 and 2018.

The global market for cancer profiling reached $26.1 billion in 2012 and nearly $30.1 billion in 2013 and is expected to reach $54.8 billion in 2018, a compound annual growth rate of 12.8% over the five-year period, 2013 to 2019.

Learn More

List of major Universities related to Cancer Science in USA: 

Stanford University | California | Duke University | North Carolina | University of Chicago | Chicago | Vanderbilt University | Tennessee | Georgetown University | Washington | University of Michigan-Ann ArborMichigan | University of Southern California | Los Angeles | Wake Forest University | North Carolina | University of Wisconsin-Madison | Wisconsin | Madison | University of Miami | Florida | University of the Sciences | Pennsylvania | University of Utah | Utah | University of Arizona | Arizona | University of Toledo | Ohio | Wayne State University | Michigan

List of major Universities related to Cancer Science in Europe:

Kingston University Life Sciences | England | University of Birmingham School of Life Sciences | England | Brunel University | LondonCardiff University | Wales | University of Edinburgh | Scotland | Newcastle University | Northern Institute for Cancer Research | England | University of Bradford England | University of Bristol  England | University of Buckingham | England | University of Cambridge | England | University College Dublin | Republic of Ireland | Edge Hill University | England | Harper Adams UniversityEngland | University of Hull | England

List of major Universities related to Cancer Science in Asia:

University of Tokyo | Tokyo | National University of Singapore | Singapore |  Kyoto University | Tokyo | University of Hong Kong | Hong Kong | Peking University | China | Seoul National University | South Korea | National Taiwan University | Taiwan | Osaka University | Japan | Tsinghua University | China | The Chinese University of Hong Kong | Hong Kong | Fudan University | China | Taipei Medical University | Taiwan | Mahidol University | Thailand | Tohoku University | Japan | Kyushu University | Japan | University Malaya | Malaysia | Indian Institute of Science | India | Nanjing University | China | University of Indonesia | Indonesia | University of the Philippines | Philippines

List of major Societies related to Cancer Sciences in USA:

American association of cancer research | American Board of Preventive Medicine (ABPM) | American College of Epidemiology | American Heart Association Council on Epidemiology and Prevention | American Public Health Association

American Society of Preventive Oncology | Association for Professionals in Infection Control Control and Epidemiology Inc. | American Statistical Association (ASA) | Section on Statistics in Epidemiology (SIE) | Association for Prevention Teaching and Research (APTR) | Canadian Society for Epidemiology and Biostatistics | Council of State and Territorial Epidemiologists (CSTE) | Health Monitoring Systems| Inc.| International Clinical Epidemiology Network (INCLEN) | International Epidemiological Association | International Society for Environmental Epidemiology (ISEE) | International Society for Pharmacoepidemiology | Netherlands Epidemiological Society | American Academy of Pediatrics | Section on Epidemiology | Society for Clinical Trials| Inc. | Society for Heathcare Epidemiology of America

List of major Societies related to Cancer Sciences in Europe:

European Oncology Nursing Society (EONS) | European Society for Medical Oncology (ESMO) |  British Association for Cancer Research (BACR) | Association for international Cancer Research (AICR) | European School of Oncology (ESO) | International Epidemiological Association  International Society for Environmental Epidemiology (ISEE)  | International Society for Pharmaco epidemiology | SGMO Swiss Society for Medical Oncology

List of major Societies related to Cancer Sciences in Asia:

Chinese Society of Clinical Oncology | Association of Oncology Social Work (AOSW) | Association of Pediatric Hematology Oncology Nurses (APHON) | Association of Pediatric Oncology Social Work (APOSW) | Health Monitoring Systems, Inc. | International Clinical Epidemiology Network (INCLEN) | International Epidemiological Association | International Society for Environmental Epidemiology (ISEE)Association of Radiation Oncologists of IndiaJapanese Breast Cancer Society |  Asian Cancer Foundation |  Japan Lung Cancer Society | Cancer Relief Society Nepal

List of major Conferences related to Cancer Sciences in USA:

Oncology Conferences USA 2018 | Oncology Conferences Canada 2018 | Oncology Conferences Japan 2018 | Cancer Conferences Japan 2018 | International Cancer Imaging Conferences October 2-4 | Oncology Conference USA, 2018 | 8th International EMT Meeting, Texas, US | Cancer Epigenetics: New Mechanisms, New Therapies, Colorado, US | WCC-2017 World Cancer Conference, Chicago, US | Cancer Imaging and Therapy, Florida, US

List of major Conferences related to Cancer Sciences in Europe:

9thWorld Biomarkers Conferences December 07-08, 2017 Madrid, Spain | 12th World Hematology Conferences March 15-16, 2018 London, UK | 7th World Breast Cancer Conferences May 10-11, 2018 Frankfurt, Germany | 2nd International Epigenetics Conferences and Chromatin Conferences November 06-08, 2017 Frankfurt, Germany | 27th International Oncology research Conferences and Cancer Stem cells Conferences May 10-12, 2018 Frankfurt, Germany | International Oncology Conferences and Cancer Diagnosis Conferences August 28-30, 2017 Brussels, Belgium |  Oncology Conferences Asia 2018 | 20th Europe Cancer Therapy Conferences and Radiation Oncology Conferences August 28-29, 2017 Brussels, Belgium |  25th World Cancer Conferences October 19-21, 2017 Rome, Italy |  Global Cancer Therapy Conferences August 07-09, 2017 Frankfurt, Germany |  In vivo model of metastasis Conferences   November 27-29, 2017 Berlin, Germany | European Cancer Conferences September 7-9, 2018 Vienna, Austria |  9th European Urological Cancer Conferences November 16-19, 2017 Barcelona, Spain

List of major Conferences related to Cancer Sciences in Asia:

ESMO Summit Middle East, 2018 | ESMO Asia 2107 Congress, Singapore | Frontiers in Cancer Science 6-8th November 2017, Singapore | Indo-Oncology Summit-2018, India |  Cold Spring Harbor Asia conference on Precision Cancer Biology |  From Targeted to Immune Therapies, China | Asia Lung Cancer Summit in Hong Kong Targets Precision Medicine , Hong Kong |  Frontiers in Cancer Science-2017, Singapore | 3rd Multidisciplinary Lung Cancer Coneference-2017, Singapore | 13th National Conference of the Asian Clinical Oncology Society, Thailand

List of major Journals related to Cancer Sciences in USA:

Cancer Cell | Journal of Clinical Oncology | Journal of the National Cancer Institute | Clinical Cancer Research | Stem Cells | CancerMolecular Cancer Therapeutics | International Journal of Radial Oncology Biology Physics | Journal of the National Comprehensive Cancer Network | Advances in Cancer Research | Oncotarget | Journal of Cancer Survivorship | Cancer Prevention Research | Seminars in  Oncology | Annals of Surgical Oncology | Seminars in Radiation  oncology | Journals of Thoracic Oncology | Current Opinion in Oncology | Cancer Control | Cancer Cytopathology

List of major Journals related to Cancer Sciences in Europe:

Lancet Oncology | Drug Resistance Updates | Breast Cancer Research | European Journal of Cancer | Nature Reviews Clinical Oncology | British Journal of Cancer | Blood Reviews  | Molecular Cancer | Endocrine-Related Cancer | Psycho-Oncology | Pigment Cell and Melanoma Research | Cancer Science | Environmental Carcinogenesis and Ecotoxicology Reviews | Journal of Hematology and Oncology

List of major Journals related to Cancer Sciences in Asia:

Asian Pacific Journal of Cancer Prevention | Asian Pacific Journal of Cancer Prevention | The Japanese Association of Medical Sciences | Angiogenesis in Multiple Myeloma: Implications in Myeloma Therapy | Lymphoma in Asia | Arsenates in the Treatment of Hematological Malignancies | Endoscopic Diagnosis and Treatment for Early Gastric Cancer Asia Pacific Journal of Public Health | Liver Cancer

List of jobs related to Cancer Sciences:

Nanoscience Faculty Postdoctoral Position Tenure-track Assistant Professor | Assistant/Associate/Full Professor - Physiology and Biophysics | Postdoctoral Associate | Associate/Full Professor of Oral Biology | Postdoctoral Fellow in Cancer BiologyEnvironmental Epidemiologist | Assistant Professor Biology | Postdoctoral Research Fellow | Postdoctoral Fellow in cancer metabolism | Faculty Positions in TranslationalSensory Neuroscience and Cancer | Postdoctoral Positions in Immunology | Cancer Immunologist & System biologist | Assistant Professor In Developmental Genetics | Research Technician | Principal Research Technician | Equipment Management Associate | Senior Research Tech | Senior Scientist | Animal Research Technician | Senior Research Funding Manager | Senior Medical Writer | Research Assistant | Molecular Field Applications Specialist | Lead Scientist – Immunochemistry | Senior Research Technician | Scientific Project Manager | Editorial Associate Director | Senior Biomedical Scientist: Molecular Profiling | Clinical Scientist/NGS Data Analyst | Field Application Scientist | Senior Cancer Analyst | Senior Translational Scientist | Clinical Laboratory Processing Technician | Principal Medical Writer | Product Manager | Product Support Scientist | Senior Quality Assurance Officer | Data Scientist – Bioinformatics | Research Scientist – Bioinformatics | Senior Principal Upstream Process Development Scientist | Senior Cancer Analyst | Cell Line Development Scientist | Associate Principal Scientist

 

Past Conference Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Cancer Science – 2018 Conference the successful!

1st Edition of World congress on Cancer Science – 2018, hosted by the Euroscicon Ltd. was held during July 23-24, 2018 at HYATT PLACE, Amsterdam, Netherlands based on the theme “The Current Advancements in Cancer science-2018 " which got magnificent response. With the support and guidance of Organizing Committee Members and Editorial Board Members and astonish presentations of all participants along with Scientists, Researchers, Students and leaders from various fields of Oncology made this event a grand success.

Euroscicon Ltd expresses its gratitude to the conference Moderator, namely Dr. Mohamed Mostafa Rizk, University of Alexandria, Egypt for taking up the responsibility to coordinate during the sessions for smooth functioning of this event. We are indebted to your support. A very special thanks to our Exhibitors and Sponsors to have bestowed and their faith and invested in us to make this event a fruitful one. We hope you continue your support in our future endeavours. The conference was initiated with the Honourable presence of the Keynote forum. The speakers list includes: 

  • Dr. Weisi Yan, University of South Alabama, USA
  • Dr. Donglu Shi, University of Cincinnati, USA
  • Dr. Igor Smit, Ijsselland Ziekenhuis, Netherlands
  • Dr. Kenji Ohe, Fukuoka University, Japan
  • Dr. Dwayne N. Jackson, University of Western Ontario, Canada
  • Dr. Mohamed Mostafa Rizk, University of Alexandria, Egypt
  • Dr. Jiangwen Zhang, University of Hong Kong, Hong Kong
  • Dr. María del Rosario Davalos Gamboa, University of San Simon, Bolivia
  • Dr. Jose Antonio Matute Briceno, Sonora Cancer Research Center-Cics USA, Mexico
  • Dr. Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria
  • Dr. Mohammed Y Almaghrabi, Jing Abdullah Medical City, Kingdom of Saudi Arabia
  • Dr. Jan Jacques Michiels, Goodheart Institute and Foundation in Nature Medicine & Health, Netherlands
  • Dr. Kamlesh Guleria, Guru Nanak Dev University, India
  • Dr. Adnan Yousif Rojeab, London College UCK, U.K
  • Dr. Marjan Jalalimehr, Razi institute, Iran
  • Dr. George Kunudji, Bikbok Herbal Centre, Ghana
  • Dr. Jana Slobodníkova, Alexander Dubcek University of Trencin, Slovakia
  • Dr. Dina Ron, Israel Institute of Technology, Israel

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Immuno-Oncology Studies
  • Oncology
  • Clinical Oncology
  • Tumor Immunology
  • Types Of Cancer
  • Cancer Research & Cancer Vaccines
  • Antibody Therapy Of Cancer
  • Combining Cancer Immunotherapies
  • Immune Checkpoint Inhibitors
  • Radiology And Imaging In Cancer
  • Cancer Prognosis & Diagnosis
  • Cancer Micro And Immuno Environment
  • Stem Cell Therapy
  • Biomarker And Drug Targeting
  • Cancer Pharmacology
  • Cancer Biomarkers
  • Cancer Genomics And Metabolomics
  • Immuno-Oncology Studies
  • Cancer & HIV
  • Neuro Immunology
  • Tumor Immuno Therapy Research
  • Radiation Oncology

Euroscicon Ltd also took the privilege of felicitating and Cancer Science – 2018 Organizing Committee, Editorial Board Members of Archives in Cancer Research, Keynote Speakers, Chair and Co-Chairs, Moderator and Exhibitor who supported this event. With the grand success of Cancer Science – 2018, Euroscicon Ltd is proud to announce the “International conference on Cancer Science – 2019" to be held soon.

For More details visit: https://cancerscience.euroscicon.com/2018

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Talk to Us

Speak directly to one of our conference representatives by calling.


+0044-2033180199

Mail Us

E-mail us your questions about the conference. We will respond to your questions.


contact@euroscicon.com

Contact Us

Have questions?
We'll be in touch within 24 hours.


Contact Us

Address

EuroSciCon Ltd
35 Ruddlesway,
Windsor, Berkshire,
SL4 5SF, UK

EuroSciCon Events are produced by Euroscicon Ltd

EuroSciCon, founded in 2001 is a UK based independent life science Events Company with predominantly business and academic client base. The key strategic objective of EuroSciCon is to communicate science and medical research between academia, clinical practice and the pharmaceutical industry. Most of its events are in Europe and London or live streamed. EuroSciCon expanded its operations to international in association with Meetings International, Singapore. All major meetings of EuroSciCon and Meetings International will issue Continued Professional Education (CPD), Continued Education (CE), Continued Medical Education (CME) Credits.